Queen's University Belfast and Fusion Antibodies
Lead Participant:
QUEEN'S UNIVERSITY BELFAST
Abstract
To develop new innovative processes to create a novel platform technology for the generation and maturation of fully human antibodies that can be rapidly progressed by clients into clinical development.
Lead Participant | Project Cost | Grant Offer |
|---|---|---|
| QUEEN'S UNIVERSITY BELFAST | £232,264 | £ 155,617 |
Participant |
||
| KTN LTD | ||
| QUEEN'S UNIVERSITY BELFAST |
People |
ORCID iD |